References
- Ellerin T, Rubin RH, Weinblatt ME. Infections and anti-tumor necrosis factor alpha therapy. Arthritis Rheum. 2003;48:3013–22.
- Strangfeld A, Listing J. Infection and musculoskeletal conditions: bacterial and opportunistic infections during anti-TNF therapy. Best Pract Res Clin Rheumatol. 2006;20:1181–95.
- Arnett EC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatology Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–24.
- Ohzato H, Yoshizaki K, Nishimoto N, Ogata A, Tagoh H, Monden M, et al. Interleukin-6 as a new indicator of inflamma-tory status: detection of serum levels of interleukin-6 and C-reactive protein after surgery. Surgery. 1992;111:201–9.
- Mackiewicz A, Speroff T, Ganapathi MK, Kushner I. Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines. J Immunol. 1991;146:3032–7.
- Nishimoto N, Terao K, Mima T, Nakahara H, Takagi N, Kakehi T. Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease. Blood. 2008;112: 3959–64.
- Hirao M, Hashimoto J, Tsuboi H, Nampei A, Nakahara H, Yoshio N, et al. Laboratory and febrile features after joint surgery in patients with tocilizumab. Ann Rheum Dis. 2009;68:654–7.
- Niimi M, Wada Y, Sato M, Takahara J, Kawanishi K. Effect of continuous intravenous injection of interleukin-6 and pretreat-ment with cyclooxygenase inhibitor on brain c-fos expression in the rat. Neuroendocrinology. 1997;66: 47–53.
- Wang JP, Dunn AJ. Mouse interleukin-6 stimulates the HPA axis and increases brain tryptophan and serotonin metabolism. Neu-rochem Int. 1998;33:143–54.
- Besedovsky HO, Del Ray A, Futukawa H, Arditi GM, Kabiersch A. Cytokines as modulators of the hypothalamus-pituitary-adrenal axis. J Steroid Biochem Mol Biol. 1991;40:613–8.
- Van der Meer MJM, Sweep CGJ, Rijnkels CEM, Pesman GJ, Tilders FJH, Kloppenborg PWC, Hermus ARMM. Acute stimu-lation of the hypothalamic-pituitary-adrenal axis by IL-1/3, TNFa and IL-6: a dose response study. J Endocrinol Invest. 1996;19:175–82.
- Noun i AME, Panayi GS, Goodman SM. Cytokines and the chronic inflammation of rheumatic disease: I. The presence of interleukin-1 in synovial fluids. Clin Exp Immunol. 1984;55: 295.
- Di Giovine FS, Nuki G, Duff GW. Tumour necrosis factor in synovial exudates. Ann Rheum Dis. 1988;47:768–72.
- Newcombe DS, Fahey JV, Ishikawa Y. Hydrocortisone inhibition of the bradykinin activation of human synovial fibroblasts. Prostaglandins. 1977;13:235.
- Oguogho A, Alomaka CP, Ereigbre AB. Depressed endothelium-dependent relaxation responses to acetylcholine and histamine in isolated human epigastric arteries from pre-eclamptic women. Clin Auton Res. 1996;6:153–5.
- Suzuki Y, Yamamoto T, Suzumori K, Kajikuri J, Itoh T. Modi-fied histamine-induced NO-mediated relaxation in resistance arteries in pre-eclampsia. Eur J Pharmacol. 2000;410:7–13.
- Cockell AP, Poston L. Flow-mediated vasodilatation is enhanced in normal pregnancy but reduced in preeclampsia. Hypertension. 1997;30:247–51.